Key Highlights: Implications: Kashiv’s scaling challenges Biocon/Serum Institute dominance in India’s $15B+ biologics CDMO space (18% CAGR), capturing 10-15% complex...
Home / BiotechInvestment
Browsing Tag: BiotechInvestment
Featured Posts

Your Compass In Indian Pharma
Key Highlights: Implications: Kashiv’s scaling challenges Biocon/Serum Institute dominance in India’s $15B+ biologics CDMO space (18% CAGR), capturing 10-15% complex...